SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Repligen Corp (RGEN)
An SI Board Since February 1996
Posts SubjectMarks Bans Symbol
395 38 0 RGEN
Emcee:  Rajiv Hargunani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
345Is this a new direction for RGEN? Opening added over the weekend: Process DevHarvey Allen-12/16/2007
344To me it's how you want to spend the next two years. Repligen deflated twoHarvey Allen-12/16/2007
343Hello Harvey - Wonder if you receive this on Silcion Investor or yahoo - let meBob Laz-12/16/2007
342<i>some sort of patent settlement with BMY </i> I can go for that. Harvey Allen-12/15/2007
341I doubt if this most enjoyable stock price move has anything much to do with theBiomaven-12/15/2007
340Quantify- Why look for a buyout? Nobody is going to overpay for RGEN. We are so Harvey Allen-12/14/2007
339Maybe somebody else might have an informed opinion, Steve, I just post these Mertom pope-12/4/2007
338Is RGEN going to win another lawsuit? Look at volume today and price has been hSteve Lokness-12/4/2007
337Merrill. Payment does not impress. No royalties to Repligen/MIT, but Yeda appeatom pope-9/10/2007
336siliconinvestor.comDewDiligence_on_SI-9/10/2007
335Sorry, I haven't; never followed the company closely or had a position. Pettuck-9/10/2007
334tuck; Have you followed this lawsuit at all? Market doesn't like it......Steve Lokness-9/10/2007
333>>Repligen Announces Settlement with ImClone In Erbitux(R) Lawsuit Monday tuck-9/10/2007
332More seriously; Seems to me that if IMCL wants to sell the company, they really Steve Lokness-7/31/2006
331IMCL was looking for a buyer, maybe RGEN should do it. <g> SteveSteve Lokness-7/31/2006
330The worst case for IMCL is probably having to pay a royalty of a few percentage DewDiligence_on_SI-7/31/2006
329Repligen Wins Summary Judgment Against ImClone in Erbitux(R) Case PR Newswire - sjemmeri-7/31/2006
328RGEN/MIT lawsuit update: biz.yahoo.com >> Repligen and MIT previously fiDewDiligence_on_SI-2/9/2006
327Here's another old but good description of the case: MIT Sues ImClone, DispBiomaven-1/31/2006
326As I understand this-----MIT/RGEN developed the cell line that was used. This ccddog1-1/31/2006
325My understanding is the Imclone lawsuit is being handled on a contingency basis.Harvey Allen-1/7/2006
324Thanks - I hadn't realized that. I can't say I have followed the ErbituxBiomaven-1/7/2006
323<i>I don't know if they can get anything for the prior infringement ifDewDiligence_on_SI-1/6/2006
322fun to know the machinations, thus the thanx.scaram(o)uche-1/6/2006
321That Erbitux case seems like a stretch to me, at least insofar as the patent extBiomaven-1/6/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News